Società Italiana di Endocrinologia

The Italian Society of Endocrinology (SIE) is a prestigious organization that unites leading professionals in the field of endocrinology, fostering collaboration among scientists and clinicians across various specialties. SIE focuses on advancing research and education in endocrine disorders, providing resources for both healthcare professionals and patients. The society organizes significant events, including national congresses like the GEMM 2024 and the 2nd National Congress on Geriatric Endocrinology, aiming to disseminate the latest clinical findings and treatment protocols.

In addition to its educational initiatives, SIE informs its members about emerging therapies, such as the recent availability of Tirzepatide (Mounjaro) in Italy, a novel medication for metabolic health. Committed to improving patient outcomes, SIE also publishes research in renowned journals and offers various tools and calculators for clinical practice. With a focus on both common and rare endocrine diseases, SIE strengthens the community's response to endocrine healthcare, making a significant impact on patient lives in Italy and beyond.